» Articles » PMID: 29378596

Myeloid-derived Suppressor Cells in Transplantation: the Dawn of Cell Therapy

Overview
Journal J Transl Med
Publisher Biomed Central
Date 2018 Jan 31
PMID 29378596
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Myeloid-derived suppressor cells (MDSCs) are a series of innate cells that play a significant role in inhibiting T cell-related responses. This heterogeneous population of immature cells is involved in tumor immunity. Recently, the function and importance of MDSCs in transplantation have garnered the attention of scientists and have become an important focus of transplantation immunology research because MDSCs play a key role in establishing immune tolerance in transplantation. In this review, we summarize recent studies of MDSCs in different types of transplantation. We also focus on the influence of immunosuppressive drugs on MDSCs as well as future obstacles and research directions in this field.

Citing Articles

Galectin-1 is associated with hematopoietic cell engraftment in murine MHC-mismatched allotransplantation.

Shaikh A, Gangaplara A, Kone A, Almengo K, Kabore M, Ali M Front Immunol. 2024; 15:1411392.

PMID: 39351218 PMC: 11439684. DOI: 10.3389/fimmu.2024.1411392.


Resolvin D2/GPR18 signaling enhances monocytic myeloid-derived suppressor cell function to mitigate abdominal aortic aneurysm formation.

Bellotti P, Ladd Z, Leroy V, Su G, Sharma S, Hartman J FASEB J. 2024; 38(18):e70067.

PMID: 39320982 PMC: 11433576. DOI: 10.1096/fj.202400414RRR.


MerTK-dependent efferocytosis by monocytic-MDSCs mediates resolution of ischemia/reperfusion injury after lung transplant.

Leroy V, Manual Kollareth D, Tu Z, Valisno J, Woolet-Stockton M, Saha B JCI Insight. 2024; 9(19).

PMID: 39172530 PMC: 11466183. DOI: 10.1172/jci.insight.179876.


Chimerism-Mediated Tolerance in Intestinal Transplantation.

Crosby K, Long K, Fu J Gastroenterol Clin North Am. 2024; 53(3):413-430.

PMID: 39068003 PMC: 11284277. DOI: 10.1016/j.gtc.2023.12.009.


Knowledge, attitude, and practice toward postoperative self-management among kidney transplant recipients.

Huang X, Xi B, Xuan C, Bao Y, Wang L, Peng F BMC Med Educ. 2024; 24(1):652.

PMID: 38862944 PMC: 11167737. DOI: 10.1186/s12909-024-05631-8.


References
1.
Highfill S, Rodriguez P, Zhou Q, Goetz C, Koehn B, Veenstra R . Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13. Blood. 2010; 116(25):5738-47. PMC: 3031417. DOI: 10.1182/blood-2010-06-287839. View

2.
Wegner A, Verhagen J, Wraith D . Myeloid-derived suppressor cells mediate tolerance induction in autoimmune disease. Immunology. 2017; 151(1):26-42. PMC: 5382345. DOI: 10.1111/imm.12718. View

3.
Chesney J, Mitchell R, Yaddanapudi K . Myeloid-derived suppressor cells-a new therapeutic target to overcome resistance to cancer immunotherapy. J Leukoc Biol. 2017; 102(3):727-740. PMC: 6608049. DOI: 10.1189/jlb.5VMR1116-458RRR. View

4.
Holmgaard R, Zamarin D, Li Y, Gasmi B, Munn D, Allison J . Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner. Cell Rep. 2015; 13(2):412-24. PMC: 5013825. DOI: 10.1016/j.celrep.2015.08.077. View

5.
Drujont L, Carretero-Iglesia L, Bouchet-Delbos L, Beriou G, Merieau E, Hill M . Evaluation of the therapeutic potential of bone marrow-derived myeloid suppressor cell (MDSC) adoptive transfer in mouse models of autoimmunity and allograft rejection. PLoS One. 2014; 9(6):e100013. PMC: 4057339. DOI: 10.1371/journal.pone.0100013. View